SMI
11.791,91
PKT
-135,20
PKT
-1,13
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
13.12.21 | UBS Buy | Kepler Cheuvreux | |
13.12.21 | Zurich Insurance Overweight | Barclays Capital | |
13.12.21 | Swiss Re Overweight | Barclays Capital | |
13.12.21 | Roche Neutral | Credit Suisse Group | |
13.12.21 | Roche Neutral | JP Morgan Chase & Co. | |
13.12.21 | Novartis Neutral | Credit Suisse Group | |
13.12.21 | Zurich Insurance Overweight | Morgan Stanley | |
10.12.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
10.12.21 | Roche Neutral | JP Morgan Chase & Co. | |
09.12.21 | Holcim Overweight | Barclays Capital | |
08.12.21 | Nestlé Overweight | Barclays Capital | |
08.12.21 | Nestlé Buy | Goldman Sachs Group Inc. | |
08.12.21 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
08.12.21 | Nestlé Buy | UBS AG | |
08.12.21 | Nestlé Overweight | JP Morgan Chase & Co. | |
08.12.21 | Holcim Outperform | Credit Suisse Group | |
08.12.21 | Holcim Neutral | JP Morgan Chase & Co. | |
08.12.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
08.12.21 | Givaudan Neutral | UBS AG | |
08.12.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
07.12.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
07.12.21 | ABB (Asea Brown Boveri) Buy | UBS AG | |
07.12.21 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
07.12.21 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.12.21 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
07.12.21 | Holcim Outperform | Credit Suisse Group | |
07.12.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
07.12.21 | Roche Buy | Jefferies & Company Inc. | |
07.12.21 | Novartis Buy | Jefferies & Company Inc. | |
06.12.21 | Swiss Re Neutral | Credit Suisse Group | |
06.12.21 | Novartis Sell | Deutsche Bank AG | |
06.12.21 | UBS Overweight | JP Morgan Chase & Co. | |
06.12.21 | UBS Neutral | UBS AG | |
04.12.21 | Zurich Insurance Outperform | Credit Suisse Group | |
03.12.21 | Novartis Neutral | UBS AG | |
03.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
03.12.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
03.12.21 | UBS Buy | Jefferies & Company Inc. | |
02.12.21 | Roche Neutral | UBS AG | |
02.12.21 | UBS Outperform | RBC Capital Markets |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.